3 weeks ago
41
Immunotherapy may offer a completely new way to treat people with difficult-to-treat depression, according to a University of Bristol-led clinical trial published in JAMA Psychiatry on May 20.
In the small pilot study, researchers tested whether tocilizumab, a drug commonly prescribed for inflammatory conditions such as rheumatoid arthritis, could ease depression symptoms in patients who had not improved with standard antidepressants.
Although ...
English (US) ·